Endoscopic Devices - Gambia | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Gambia is anticipated to reach US$202.10k in 2024.
The revenue in this market is projected to exhibit an annual growth rate (CAGR 2024-2029) of 7.56%, which will lead to a market volume of US$291.00k by 2029.
In a broader context, the majority of revenue will be generated the United States, with figures amounting to US$10.39bn in 2024.
In Gambia, the increasing focus on improving healthcare infrastructure is driving demand for advanced endoscopic devices, enhancing diagnostic and therapeutic capabilities.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Gambia is witnessing considerable growth, fueled by advancements in minimally invasive procedures, increasing healthcare investments, and a rising demand for diagnostic and therapeutic interventions among healthcare providers.

Customer preferences: In Gambia, there is a growing preference for advanced medical solutions that emphasize patient comfort and faster recovery times, driving interest in endoscopic devices. As the population becomes more health-conscious and informed, patients are increasingly opting for minimally invasive procedures over traditional surgeries. Cultural shifts towards preventative healthcare and the desire for quicker return to daily activities are influencing healthcare providers to invest in state-of-the-art endoscopic technologies, enhancing diagnostic accuracy and therapeutic outcomes.

Trends in the market: In Gambia, the Endoscopic Devices Market is experiencing a significant shift toward minimally invasive surgical techniques, driven by an increasing demand for patient-centric healthcare solutions. As awareness of the benefits of endoscopic procedures grows, healthcare providers are investing in advanced technologies that improve surgical precision and reduce recovery times. Furthermore, the integration of training programs for medical professionals in endoscopic techniques is becoming more prevalent. This trend signifies a transformation in surgical practices, enhancing patient outcomes and expanding the market, ultimately benefiting manufacturers and healthcare facilities aiming for competitive advantage and improved service delivery.

Local special circumstances: In Gambia, the Endoscopic Devices Market is influenced by a combination of unique geographical and cultural factors. The country's limited healthcare infrastructure necessitates the adoption of cost-effective solutions that minimize the need for extensive surgical facilities. Additionally, cultural attitudes towards traditional healing practices often coexist with modern medical approaches, creating a demand for less invasive procedures. Regulatory support for the importation of advanced medical technologies further enhances accessibility, enabling healthcare providers to offer improved surgical options that align with local patient preferences and needs.

Underlying macroeconomic factors: The Endoscopic Devices Market in Gambia is significantly shaped by macroeconomic factors such as national economic stability, healthcare funding, and global economic trends. With a growing emphasis on cost-effective healthcare solutions, investment in medical technology is crucial for enhancing service delivery. The country's healthcare expenditure, influenced by fiscal policies and international aid, affects the procurement of advanced endoscopic devices. Furthermore, global trends towards minimally invasive procedures drive demand, while local economic conditions, including employment rates and disposable income, impact patient access to these innovative medical solutions.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.